Target-based Classification of Drugs

[ Brite menu | Download htext | Download json | Help ]
Search

1st Level  2nd Level  3rd Level  4th Level  5th Level 

     Type
 G Protein-coupled receptors
 
 Ion channels
 
 Nuclear receptors
 
 Protein kinases
 
 Cytokines and receptors
 
 Cell surface molecules and ligands
 
 Transporters
 
 Enzymes
 
 Nucleic acids
 
 Not elsewhere classified
   Signaling molecules
   Cellular process
   Organismal systems
     Complement and coagulation
       F8 [HSA:2157] [KO:K03899]
       F11 [HSA:2160] [KO:K01323]
       VWF [HSA:7450] [KO:K03900]
         D11160  Caplacizumab (USAN/INN) <US>
         D10758  Turoctocog alfa pegol (genetical recombination) (JAN) <JP>
Monoclonal antibody
 
       KNG1 [HSA:3827] [KO:K03898]
       C3 [HSA:718] [KO:K03990]
       C5 [HSA:727] [KO:K03994]
       C5 (C5a) [HSA:727] [KO:K03994]
       SERPINC1 (AT3) [HSA:462] [KO:K03911]
       SERPIND1 [HSA:3053] [KO:K03912]
       SERPINE1 (PAI1) [HSA:5054] [KO:K03982]
       TFPI [HSA:7035] [KO:K03909]
     Immune system
     Endocrine system
     Circulatory system
     Digestive system
     Nervous system
   Unclassified

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: December 2, 2020

» Japanese version